The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

Dose-ranging pharmacokinetics, safety, and efficacy of a 90-day intravaginal ring delivering islatravir in pigtail macaques

Intravaginal rings (IVRs) are attractive user-controlled delivery systems that can achieve sustained release of compounds for several weeks. We modeled in macaques a three-dimensional (3D)–printed IVR delivering the investigational nucleoside reverse transcriptase translocator inhibitor islatravir (ISL). Three IVRs with 15, 30, or 60 milligrams of ISL were used in 30-day pharmacokinetic and safety studies followed […]

Srinivasan, P., King, J. L., Zhang, J., Young, I. C., Little, D., Cottrell, M. L., Sykes, C., Schauer, A. P., Mitchell, J., Kashuba, A. D. M., García-Lerma, J. G., Benhabbour, S. R., Smith, J. M. Visit Resource August 2026

From Insight to Innovation: Integrating User Preferences into MPT Development

This session of the IMPT’s Let’s Talk MPTs webinar series will explore how women’s perspectives can shape the next generation of MPTs. Join us to hear new findings on user experiences with an investigational vaginal film for HIV prevention and contraception, alongside U.S.-based research on preferences for MPT product characteristics. Presenters:Alexandra Minnis, PhD, MPH (RHI […]

Alexandra Minnis, PhD, MPH (RHI International), Nyaradzo Mgodi, MD (University of Zimbabwe–Clinical Trials Research Centre (UZ-CTRC), Ann Gottert, PhD, MPH (Population Council) and the IMPT. Visit Webinar July 2026

A snapshot of how U.S. funding cuts impacted HIV care in one county of Kenya: a qualitative case study

Sedlander, E., Lawson, K., Wairimu, N., Werner, K., Mutai, S., Mwai, D., Gandhi, M., Ngure, K. Visit Resource July 2026

‘ … they just take one pill, so it is easy to use, more convenient … ’: South African health care provider perspectives on a Dual Prevention Pill

The Dual Prevention Pill (DPP) is a daily oral pill containing oral pre-exposure prophylaxis (PrEP) for protection against HIV and a combined oral contraceptive (COC) for the prevention of unintended pregnancy, currently under development. However, little is known about healthcare providers’ (HCPs) perspectives on this potential new multipurpose prevention technology (MPT). A more granular understanding […]

Mathur, S., Tenza, S., Begg, L., Mampuru, L., Bruce, I. V., Moji, M., Ndlovu, N., Reddy, K., Palanee-Phillips, T., Friedland, B. A. Visit Resource May 2026

Recommendations for Expanding Regulatory Agility and Evidentiary Integrity in Developing Treatments for Rare Diseases

Reagan-Udall Foundation for the Food and Drug Administration (FDA) April 2026

Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial

Mhlanga, F.G., Szydlo, D.W., Mayo, A.J., Bunge, K., Fairlie, L., Nakabiito, C., Musara, P., Mgodi, N.M., Dadabhai, S., Scheckter, R., Anderson, P.L., Marzinke, M.A., Chappell, C., Gadama, L.A., Richardson, B.A., Piper, J.M., Hillier, S.L. March 2026
Advancing Vaginal Health Products: Addressing BV and STI/HIV Prevention Through Next-Generation MPTs

Advancing Vaginal Health Products: Addressing BV and STI/HIV Prevention Through Next-Generation MPTs

This session of IMPT’s Let’s Talk MPTs webinar series explores how next-generation multipurpose prevention technologies (MPTs) can integrate BV management with STI/HIV prevention in single, user-controlled products. Bacterial vaginosis (BV) significantly increases vulnerability to HIV and other sexually transmitted infections (STIs), yet remains under-addressed in prevention strategies. Presenters: Ishita Shah, PhD (Matrubials, Inc.) discussed antimicrobial […]

Jen Balkus PhD, MPH (University of Washington | Public Health Seattle & King County), Ishita Shah PhD (Matrubials Inc.), Laurel Lagenaur PhD (Osel Inc.) and the IMPT. Visit Webinar February 2026

Multipurpose vaginal rings: preferences from a national discrete choice experiment survey among US women

Gottert, A., Mathur, S., Friedland, B.A., Abuya, T., Bruce, I.V., Burnett-Zieman, B., Plagianos, M.G., Shetty, S., Sales, J.M., Haddad, L.B. February 2026

Strengthening nationally led approaches to new product introduction for HIV prevention

Subedar, H., Ncube, N.B.Q., Kadama, H., Matanje, B., Kamya, M.R., Mugambi, C., Mudiope, P., Ajose, O., Jenkins, S.Y., Roxo, U.C., Pérez Casas, C., Warren, M., Cameron, A., Ismail, A., Odek, J., Gunda, A., Mulenga, L., Ozituosauka, W., Hamm Rush, S., Luba, M., Hoege, D., Sakala, M., Igbinosun, B.O., Burry, J., Allinder, S.M., Holmes, C.B. January 2026

Sexual and reproductive health in disasters: A systematic review of digital health and multipurpose prevention

Dewantiningrum, J., Andonotopo, W., Pramono, M.B.A., Prabowo, W., Bachnas, M.A., Sanjaya, I.N.H., Wiradnyana, A.A.G.P., Darmawan, E., Akbar, M.I.A., Gumilar, K.E., Aldiansyah, D., Andanaputra, W.E.K., Suryawan, A., Putra, R.A., Stanojeviv, M. January 2026

HIV prevention for young African women is about choice

Stewart, J., Heffron, R., Celum, C. January 2026

Bridging HIV prevention and sexual reproductive health services in the context of multi-method PrEP: a qualitative study exploring provider perceptions in South Africa

Musvipwa, F.M., Dada, S., Cholo, F.A., Pleaner, M., Letsielo, M.J., Arries, S., Kutywayo, A., Martin, C.E., Mullick, S. January 2026

Uptake of dapivirine vaginal ring and oral pre-exposure prophylaxis among women accessing HIV prevention services in South Africa: a cohort study

Martin, C.E., Ramatsoma, H., Chidumwa, G., Nongena, P., Letsielo, M.J., Kutywayo, A., Koloane, N., Ncube, S., Mdluli, N., Nattey, C., Mullick, S. January 2026

Modern contraception utilization and associated factors among adolescent girls and young women (AGYW) who participated in the Namibia DREAMS program

Moyo, E., Melese, E., Mangwana, H., Takawira, S., Harases, B., Indongo, R., Moyo, P., Makurira Nyoni, N., Dzinamarira, T. December 2025

Artificial neural network guided optimization of tenofovir and Cyanovirin-N multipurpose preventive hydrogel formulation developed using the Box Behnken design model

Oyediran, K.O., Cardoso-Daodu, I.M., Bassey, P.O., Ogundemuren, D.A., Muhammed, R., Ojo, O.E., Amenaghawon, A.N., Azubuike, C.P., Agarwal, R., Haritha, K., Ilomunaya, M.O. December 2025

Advances in drug-releasing vaginal rings

McCoy, C.F., Zhao, X., Shen, X., Bashi, Y.H.D., Murphy, D.J., Boyd, P., Malcolm, R.K. November 2025

A Dual Prevention Pill for HIV & Pregnancy Prevention: A Pilot Study Among Adolescent Girls and Young Women in Zimbabwe

Mgodi, N.M., Burnett-Zieman, J.B., Murombedzi, C., Dandadzi, A., Gatsi, V., Musara, P., Matimbira, S., Mavemwa, G., Jambaya, J., Chidemo, T., Plagianos, M., Haddad, L.B., Bruce, I.V., Mathur, S., Friedland, B.A. November 2025

Beyond the pill: contextual effects of community-based PrEP delivery on pregnancy risk among FSWs in Cameroon – a propensity score-matched analysis

Noah, J.P.Y.A., Ndongo, F.A., Ndié, J., Bonyohe, M.G., Dongmo, R.K., Komokcheua, R.B., Tabala, F.N., Ateudjieu, J., Bissek, A.C.Z.K. November 2025

Next Generation 3D Printed Multipurpose Intravaginal Ring For Sustained Co-Delivery of Antiretroviral Drugs and A Contraceptive Hormone

Dahl, D.K., Janusziewicz, R., Shrivastava, R., Maturavongsadit, P., Chan, E., Montgomery, S.A., Benhabbour, S.R. November 2025

Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them

Herron, T.J., Brüning-Richardson, A., Gough, J.E., Miller, A.F., Pilkington, G.J., Greenman, J., Speirs, V., Wu, J.C. October 2025

Dual Prevention Pill

PrEPWatch, an Initiative of AVAC. October 2025

Tenofovir and levonorgestrel vaginal MPT film developed via quality by design approach (drug release and safety evaluation in an animal model)

Muhammad, R., Bassey, P. O., Nwaneri, S. C., Cardoso-Daodu, I. M., Oladosu, A. A., Oyediran, K. O., Ilomuanya, M. O. September 2025

“…this could be a noble idea and a game changer.” The potential of a dual prevention pill for HIV and pregnancy prevention among adolescent girls and young women in Zimbabwe.

Dandadzi, A., Mathur, S., Musara, P., Bruce, I., Begg, L., Sedze, N. T., Mutero, P., Mgodi, N. M., Friedland, B. A. August 2025

Innovative Multilayered Electrospun Fiber Systems for Dual-Action HIV Prophylaxis and Non-hormonal Contraception

Ogundemuren, D. A., Bassey, P.-O. O., Oyediran, K. O., Nmesoma, O. G., Tsamos, D., Tsamis, A., Tsouknidas, A. E. June 2025

Exploring the potential of vaginal drug delivery: innovations, efficacy, and therapeutic prospects

Sanchez Armengol, E., Veider, F., Millotti, G., Kali, G., Bernkop-Schnürch, A., Laffleur, F. June 2025

Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection

Kushiro, K., Hammers, S., Zhu, Y., Flowers, H. B., Dawson, L., Panjwani, A., Schaefer, A., Quan, D., Gibb, K., McSweeney, M., Cone, R., Moench, T., Vincent, K. L., Lai, S. K. June 2025

Frontiers in Reproductive Health: Regulatory Pathways and Challenges in MPT Development

Donaldson, L., Schaefer, R., Alhakimi, S., Akulu, R., Palanee-Phillips, T., Young Holt B., Miller, V. May 2025

Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis

Vodstrcil, L.A., Plummer, E.L., Fairley, C.K., Hocking, J.S., Law, M.G., Petoumenos, K., Bateson, D., Murray, G.L., Donovan, B., Chow, E.P.F., Chen, M.Y., Kaldor, J., Bradshaw, C.S. March 2025

Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial

Gengiah, T.N., Heck, C.J., Lewis, L., Mansoor, L.E., Harkoo, I., Myeni, N., Baum, M.M., Moss, J.A., Rooney, J.F., Hankins, C., Pozzetto, B., Abdool Karim, S.S., Abdool Karim, Q. February 2025

Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development

Friedland, B.A., Gundacker, H., Achilles, S.L., Chen, B.A., Hoesley, C., Richardson, B.A., Kelly, C.W., Piper, J., Johnson, S., Devlin, B., Steytler, J., Kleinbeck, K., Dangi, B., Friend, C., Song, M., Mensch, B., van der Straten, A., Jacobson, C., Hendrix, C.W., Brown, J., Blithe, D., Hiller, S.L. January 2025

Formulation development of dual-compartment topical inserts combining tenofovir alafenamide and elvitegravir for flexible on-demand HIV prevention

Agrahari, V., Peet, M.M., Chandra, N., Ramalingam, P., Gupta, P.K., Jonnalagadda, S., Singh, O.N., McCormick, T.J., Doncel, G.F., Clark, M.R. January 2025

Dr. Robin Schaefer presents on the future of PrEP

The Forum for Collaborative Research August 2024

Tailoring drug release from long-acting contraceptive levonorgestrel intrauterine systems

Fanse, S.; Bao, Q.; Zou, Y.; Wang, Y.; Burgess, D.J. August 2024

Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3–4 November 2022

Connolly, K.L.; Bachmann, L.; Hiltke, T.; Kersh, E.N.; Newman, L.M.; Wilson, L.; Mena, L.; Deal, C. August 2024

Where’s the Equity? Including People with Disabilities in HIV Prevention Programming and Research

AVAC, Kuper, H., Maseva, T., Minalga, B., Mwikali, S., Davids, J.D., Jeckonia, P. August 2024

Next-Generation Contraceptive Intravaginal Ring: Comparison of Etonogestrel and Ethinyl Estradiol In Vitro and In Vivo Release from 3D-Printed Intravaginal Ring and NuvaRing

Young, I.C.; Thorson, A.L.; Cottrell, M.L.; Sykes, C.; Schauer, A.P.; Sellers, R.S.; Janusziewicz, R.; Vincent, K.L.; Benhabbour, S.R. August 2024

AIDS 2024 Conference by the numbers

Clinton Health Access Initiative August 2024